Inclusion Criteria:  Having a diagnosis of VTE recorded during the selection period (01-Apr-2016 to 31-May-2020 inclusive), Having a rivaroxaban prescription claim within 30 days after the VTE diagnosis , Being age 18 years or older at the index date, Having at least 180 days baseline period.  Exclusion Criteria:  Having evidence of atrial fibrillation, atrial flutter, dialysis, CTEPH (Chronic Thromboembolic Pulmonary Hypertension) or pregnancy during the baseline period, Having a claim of rivaroxaban during the baseline period.